Bangalore-Based Healthcare Startup, Leucine Rich Bio, Secures Fresh Funds In Pre Series A Funding Round

• ByStartupStory     |    October 20, 2023

Leucine Rich Bio, recognized for its innovative products designed to enhance gut microbiome health, has successfully raised an undisclosed amount in a pre-series A funding round. As India’s pioneering microbiome company, Leucine Rich Bio has garnered support from prominent doctors, including gastroenterologists and oncologists, as well as biotech entrepreneurs. This funding follows the recent opening of the company’s microbiome-focused gut health clinic in the heart of Bengaluru and its expansion into the Philippines.

In 2017, the company secured its pre-seed funding of INR 2.3 crore. Since 2022, Leucine Rich Bio has also been exporting its products to Thailand. To date, the company has exported products valued at more than INR 1800000.

Kumar Sankaran, CEO of Leucine Rich Bio, expressed his thoughts on the investment, stating, “Receiving this investment is a testament to the groundbreaking work we are doing at Leucine Rich Bio. We truly believe in the transformative potential of the microbiome in shaping the future of healthcare, especially cancer treatment and care. With this support, we are poised to take significant strides in our mission to harness the power of the microbiome to combat various chronic diseases and cancer.”

The funds obtained from this round of investment will be primarily allocated for marketing and the development of new products. This capital injection will enable the company to expand its product portfolio and enhance its research and development capabilities. Leucine Rich Bio exhibited a 20% year-on-year growth in the 2022-23 fiscal year, with a remarkable 30% quarter-on-quarter growth in the second quarter of the financial year 2023-24.

Taking a pragmatic approach to the adage “All diseases begin in the gut,” Leucine Rich Bio offers an innovative self-administered gut microbiome testing kit known as ‘BugSpeaks.’ Additionally, they provide a dietary supplement called ‘Rychbiome Indus,’ which helps replenish essential beneficial microorganisms in the gut. The company caters to a diverse customer base, including celebrities and individuals concerned about their health. Some use BugSpeaks to gain insights into their gut health and overall well-being, while others dealing with ailments such as NAFLD, IBD, IBS, type 2 diabetes, and hypertension have utilized the personalized BugSpeaks report to improve their health conditions.

In addition to the popularity of BugSpeaks, the company has witnessed a 101% increase in demand for ‘Rychbiome Indus’ during the 2022-23 period compared to 2021-22.

Follow Startup Story